/
•
•
Context is everything.
Detailed stories on technology startups, business and economic current affairs.
Detailed stories on technology startups, business and economic current affairs.
India’s only listed pharma retailer wants to rev up growth by boosting its own-brand business. But will it be enough to overcome its mounting debt, slowing revenue growth and a stalled fundraise?
Gangadi Madhukar Reddy’s MedPlus Health Services finds itself at a crossroads today.
Over the past two decades, the Hyderabad-headquartered company has grown by leaps and bounds, becoming India’s second-largest pharmaceutical retail chain. Several milestones have dotted its journey: multiple funding rounds from well-known investors (including New York-based Warburg Pincus), a stellar listing at the bourses and an ambitious foray into the diagnostics business. Yet, ever since MedPlus went public in 2021, it hasn’t all been smooth sailing.
The expansion of the diagnostics venture has been mothballed, a vital qualified institutional placement (QIP) has been put on hold and the promoters’ …
In less than two years, the instant delivery startup that puts quality above all else has attracted marquee VC investors, earning a valuation of $255 million. How far the niche bet will take it is anybody’s guess.
The Indian mother and baby products retailer has been slow to grow in the two largest markets of the Gulf. What gives?
Investors are betting on the value retail chain’s franchise model to disrupt the retail market in small-town India. By the looks of it, the six-year-old startup seems to have gotten a lot of things right.
